Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)

Anastasios Lymperopoulos

doi:10.3390/ijms242316865

Editorial for the IJMS Special Issue on Sglt2 Inhibitors (Volume 2)

Int J Mol Sci. 2023 Nov 28;24(23):16865. doi: 10.3390/ijms242316865.

Author

Anastasios Lymperopoulos¹

Affiliation

¹ Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL 33328-2018, USA.

Abstract

The goal of the second volume of this Special Issue was to build upon the success of the first one and to continue to highlight the ever-expanding list of pharmacological properties of the sodium/glucose co-transporter (SGLT) type 2 (SGLT2) inhibitor (SGLT2i) drug class (also known as gliflozins) [...].

Publication types

Editorial

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Sodium
Hypoglycemic Agents
Glucose